UCB lines up next commander-in-chief
This article was originally published in Scrip
Executive Summary
Brussels, Belgium-based UCB, which markets Crohn's disease and rheumatoid arthritis drug Cimzia (certolizumab pego), has announced that current executive vice-president Jean-Christophe Tellier will take on the role of chief executive officer in 2015.